8-K Announcements
6Material company update
Apr 16, 2026·SEC
Material company update
Apr 16, 2026·SEC
Material company update
Mar 26, 2026·SEC
MeiraGTx Holdings plc(MGTX)Earnings, Financials & Key Ratios
MGTX•NASDAQ
$9.68
$779M mkt cap·Price updated May 7, 2026
AboutMeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.Show more
- Revenue$33M+137.4%
- EBITDA-$151M-22.7%
- Net Income-$148M-75.9%
- EPS (Diluted)-2.12-42.3%
- Gross Margin28.51%-71.5%
- EBITDA Margin-454.89%+48.3%
- Operating Margin-493.44%+49.5%
- Net Margin-444.1%+25.9%
- ROE-143.48%-118.5%
- ROIC-167.75%-56.9%
- Debt/Equity1.25+93.5%
- Interest Coverage-12.37-19.6%
MGTX Key Insights
MeiraGTx Holdings plc (MGTX) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y sales CAGR of 20.1%
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗Negative free cash flow
- ✗Shares diluted 23.6% in last year
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
MGTX Price & Volume
MeiraGTx Holdings plc (MGTX) stock price & volume — 10-year historical chart
Loading chart...
MGTX Growth Metrics
MeiraGTx Holdings plc (MGTX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years20.15%
3 Years-4.07%
TTM96.83%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-91.31%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-61.07%
Return on Capital
10 Years-95.43%
5 Years-44.07%
3 Years-57.68%
Last Year-70.08%
MGTX Recent Earnings
MeiraGTx Holdings plc (MGTX) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 4/12 qtrs (33%)
Q2 2026Latest
Mar 26, 2026EPS
$0.19
Est $0.60
+131.7%
Revenue
$75M
Est $1M
+5115.3%
Q4 2025
Nov 13, 2025EPS
$0.62
Est $0.50
-24.0%
Revenue
$410,000
Est $4M
-89.4%
Q3 2025
Aug 14, 2025EPS
$0.48
Est $0.52
+7.7%
Revenue
$4M
Est $6M
-43.1%
Q2 2025
May 13, 2025EPS
$0.51
Est $0.38
-34.2%
Revenue
$2M
Est $4M
-56.6%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 26, 2026 | $0.19vs $0.60+131.7% | $75Mvs $1M+5115.3% |
| Q4 2025 | Nov 13, 2025 | $0.62vs $0.50-24.0% | $410,000vs $4M-89.4% |
| Q3 2025 | Aug 14, 2025 | $0.48vs $0.52+7.7% | $4Mvs $6M-43.1% |
| Q2 2025 | May 13, 2025 | $0.51vs $0.38-34.2% | $2Mvs $4M-56.6% |
Based on last 12 quarters of dataView full earnings history →
MGTX Peer Comparison
MeiraGTx Holdings plc (MGTX) competitors in Cell and Gene Therapy Developers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ADVM | 96.26M | 4.36 | -0.66 | -72.22% | -189.84% | 1.30 | ||
 OCGN | 487.46M | 1.44 | -6.26 | 8.83% | -15.37% | -26.26% | ||
 EDIT | 296.54M | 3.03 | -1.68 | -100% | -5.23% | 0.66 | ||
 CRSP | 5.06B | 52.42 | -8.10 | -89.97% | -138.57% | -30.88% | 0.21 | |
 NTLA | 1.62B | 13.71 | -3.60 | 16.92% | -6.1% | -56.63% | 0.14 | |
 BEAM | 3.23B | 31.47 | -38.85 | 120.01% | -49.17% | -5.89% | 0.24 | |
 SGMO | 21.54M | 0.10 | -0.21 | -67.2% | -331.28% | -8.14% | 1.34 | |
 ARWR | 10.92B | 77.95 | -6389.34 | 232.58% | -48.38% | -55.47% | 0.73 |
Compare MGTX vs Peers
MeiraGTx Holdings plc (MGTX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
MGTX Income Statement
MeiraGTx Holdings plc (MGTX) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 0 | 13.29M | 15.56M | 37.7M | 15.92M | 14.02M | 33.28M | 27.42M |
| Revenue Growth % | - | - | - | - | 17.09% | 142.25% | -57.77% | -11.95% | 137.42% | 96.83% |
| Cost of Goods Sold | 243.08K | 679.18K | 2.05M | 0 | 0 | 0 | 0 | 0 | 23.79M | 16.17M |
| COGS % of Revenue | - | - | - | - | - | - | - | - | 71.49% | - |
| Gross Profit | -243.08K▲ 0% | -679.18K▼ 179.4% | -2.05M▼ 202.3% | 13.29M▲ 747.5% | 15.56M▲ 17.1% | 37.7M▲ 142.2% | 15.92M▼ 57.8% | 14.02M▼ 12.0% | 9.49M▼ 32.3% | 11.24M▲ 0% |
| Gross Margin % | - | - | - | 100% | 100% | 100% | 100% | 100% | 28.51% | 41.01% |
| Gross Profit Growth % | - | -179.4% | -202.27% | 747.46% | 17.09% | 142.25% | -57.77% | -11.95% | -32.31% | - |
| Operating Expenses | 20.06M | 31.68M | 78.1M | 71.56M | 78.12M | 110.46M | 132.28M | 151.08M | 173.7M | 175.17M |
| OpEx % of Revenue | - | - | - | 538.37% | 501.94% | 292.99% | 830.87% | 1077.82% | 521.95% | - |
| Selling, General & Admin | 6.03M | 9.33M | 44.48M | 46.68M | 44.21M | 43.77M | 46.55M | 47.29M | 54.22M | 55.66M |
| SG&A % of Revenue | - | - | - | 351.22% | 284.05% | 116.08% | 292.4% | 337.4% | 162.91% | - |
| Research & Development | 14.04M | 22.36M | 33.62M | 24.88M | 33.91M | 66.69M | 85.72M | 103.78M | 119.48M | 122.79M |
| R&D % of Revenue | - | - | - | 187.15% | 217.89% | 176.9% | 538.47% | 740.42% | 359.04% | - |
| Other Operating Expenses | 0 | -553.5K | 83.08K | 0 | 0 | 0 | 0 | 0 | 0 | -1000K |
| Operating Income | -20.06M▲ 0% | -31.68M▼ 57.9% | -78.1M▼ 146.5% | -58.27M▲ 25.4% | -62.55M▼ 7.4% | -72.76M▼ 16.3% | -116.36M▼ 59.9% | -137.06M▼ 17.8% | -164.21M▼ 19.8% | -163.93M▲ 0% |
| Operating Margin % | - | - | - | -438.37% | -401.94% | -192.99% | -730.87% | -977.82% | -493.44% | -597.91% |
| Operating Income Growth % | - | -57.91% | -146.5% | 25.4% | -7.36% | -16.31% | -59.92% | -17.8% | -19.81% | - |
| EBITDA | -19.82M | -31.01M | -76.05M | -56.03M | -58.38M | -64.89M | -107.75M | -123.33M | -151.38M | -151.3M |
| EBITDA Margin % | - | - | - | -421.53% | -375.13% | -172.1% | -676.83% | -879.87% | -454.89% | -551.84% |
| EBITDA Growth % | - | -56.42% | -145.28% | 26.33% | -4.2% | -11.14% | -66.07% | -14.46% | -22.75% | 7.07% |
| D&A (Non-Cash Add-back) | 243.08K | 679.18K | 2.05M | 2.24M | 4.17M | 7.87M | 8.6M | 13.73M | 12.83M | 12.63M |
| EBIT | -20.06M | -31.68M | -78.1M | -54.7M | -57.85M | -79.27M | -124.67M | -70.78M | -134.52M | -156.13M |
| Net Interest Income | 6.63K | -16.79K | 19.98K | 321.99K | 1.14M | -76K | -4.17M | -10.97M | -9.13M | -9.98M |
| Interest Income | 32.07K | 26.07K | 53.41K | 370.6K | 1.28M | 212K | 777K | 2.27M | 4.14M | 2.57M |
| Interest Expense | 25.44K | 42.86K | 33.43K | 48.61K | 139.2K | 288K | 4.95M | 13.24M | 13.27M | 12.55M |
| Other Income/Expense | 272.17K | 640.19K | -5.24M | 3.52M | 4.56M | -6.8M | -13.26M | 53.03M | 16.42M | -4.76M |
| Pretax Income | -19.79M▲ 0% | -31.04M▼ 56.9% | -83.34M▼ 168.5% | -54.75M▲ 34.3% | -57.99M▼ 5.9% | -79.56M▼ 37.2% | -129.62M▼ 62.9% | -84.03M▲ 35.2% | -147.79M▼ 75.9% | -168.69M▲ 0% |
| Pretax Margin % | - | - | - | -411.87% | -372.63% | -211.03% | -814.16% | -599.46% | -444.1% | -615.27% |
| Income Tax | 0 | 0 | -474.39K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0.57% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -19.49M▲ 0% | -31.04M▼ 59.3% | -82.87M▼ 166.9% | -54.75M▲ 33.9% | -57.99M▼ 5.9% | -79.56M▼ 37.2% | -129.62M▼ 62.9% | -84.03M▲ 35.2% | -147.79M▼ 75.9% | -168.69M▲ 0% |
| Net Margin % | - | - | - | -411.87% | -372.63% | -211.03% | -814.16% | -599.46% | -444.1% | -615.27% |
| Net Income Growth % | - | -59.31% | -166.93% | 33.93% | -5.93% | -37.19% | -62.91% | 35.17% | -75.89% | -91.31% |
| Net Income (Continuing) | -19.79M | -31.04M | -82.87M | -54.75M | -57.99M | -79.56M | -129.62M | -84.03M | -147.79M | -168.69M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.01▲ 0% | -3.62▼ 258.4% | -4.37▼ 20.7% | -1.58▲ 63.8% | -1.43▲ 9.5% | -1.63▼ 14.0% | -3.16▼ 93.9% | -1.49▲ 52.8% | -2.12▼ 42.3% | -2.08▲ 0% |
| EPS Growth % | - | -258.42% | -20.72% | 63.84% | 9.49% | -13.99% | -93.86% | 52.85% | -42.28% | -61.07% |
| EPS (Basic) | -1.01 | -3.62 | -4.37 | -1.58 | -1.43 | -1.63 | -3.16 | -1.49 | -2.12 | - |
| Diluted Shares Outstanding | 19.24M | 8.57M | 18.95M | 33.16M | 37.72M | 44.14M | 45.18M | 56.49M | 69.82M | 80.95M |
| Basic Shares Outstanding | 19.24M | 8.57M | 18.95M | 33.16M | 37.72M | 44.14M | 45.18M | 56.49M | 69.82M | 80.95M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
MGTX Balance Sheet
MeiraGTx Holdings plc (MGTX) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 19.09M | 11.48M | 74.65M | 268.98M | 272.58M | 183.24M | 154.34M | 159.62M | 123.52M | 34.17M |
| Cash & Short-Term Investments | 17.48M | 8.55M | 68.08M | 227.23M | 209.52M | 137.7M | 115.52M | 129.57M | 103.66M | 14.84M |
| Cash Only | 17.48M | 8.55M | 68.08M | 227.23M | 209.52M | 137.7M | 115.52M | 129.57M | 103.66M | 14.84M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 37.11M | 55.41M | 35.02M | 29.02M | 23.41M | 10.63M | 11.81M |
| Days Sales Outstanding | - | - | - | 1.02K | 1.3K | 339.02 | 665.41 | 609.72 | 116.57 | 114.67 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 385K | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | 5.91 | 7.37 |
| Other Current Assets | 400.96K | 965.23K | 4.63M | 170.59K | 564.44K | 2.42M | 1.67M | 1.02M | 2.02M | 328K |
| Total Non-Current Assets | 3.46M | 14.38M | 22.24M | 54.91M | 91.12M | 136.92M | 163.9M | 167.12M | 146.23M | 155.3M |
| Property, Plant & Equipment | 3.02M | 14.26M | 22.01M | 52.86M | 87.12M | 126.29M | 154.09M | 156.24M | 135.65M | 144.52M |
| Fixed Asset Turnover | - | - | - | 0.25x | 0.18x | 0.30x | 0.10x | 0.09x | 0.25x | 0.20x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 777.65K | 2.97M | 2.57M | 2.08M | 1.12M | 821K | 653K |
| Long-Term Investments | 444.84K | 123.38K | 123.38K | 123.38K | 0 | 6.66M | 6.33M | 6.77M | 6.75M | 29.26M |
| Other Non-Current Assets | 0 | 0 | 105.08K | 1.15M | 1.03M | 1.4M | 1.4M | 3M | 3.01M | 10.59M |
| Total Assets | 22.55M▲ 0% | 25.85M▲ 14.6% | 96.89M▲ 274.8% | 323.89M▲ 234.3% | 363.7M▲ 12.3% | 320.16M▼ 12.0% | 318.24M▼ 0.6% | 326.74M▲ 2.7% | 269.75M▼ 17.4% | 189.47M▲ 0% |
| Asset Turnover | - | - | - | 0.04x | 0.04x | 0.12x | 0.05x | 0.04x | 0.12x | 0.12x |
| Asset Growth % | - | 14.65% | 274.77% | 234.27% | 12.29% | -11.97% | -0.6% | 2.67% | -17.44% | -130.89% |
| Total Current Liabilities | 6.04M | 21.4M | 15.5M | 49.2M | 54.15M | 68.13M | 82.07M | 67.08M | 60.78M | 152.92M |
| Accounts Payable | 1.47M | 7.06M | 3.04M | 3.76M | 7.13M | 15.35M | 16.62M | 16.04M | 23.59M | 21.54M |
| Days Payables Outstanding | 2.21K | 3.79K | 541 | - | - | - | - | - | 361.85 | 513.43 |
| Short-Term Debt | 0 | 1.44M | 27.2K | 1.67M | 2.58M | 0 | 0 | 0 | 0 | 76.53M |
| Deferred Revenue (Current) | -6.01K | 10.19M | 11.99M | 25.68M | 23.54M | 21.82M | 15.12M | 2.93M | 4.83M | 14.72M |
| Other Current Liabilities | 1.96M | 2.68M | 6.14M | 11.23M | 17.09M | 6.03M | 16.23M | 41.28M | 12.1M | 49.41M |
| Current Ratio | 3.16x | 0.54x | 4.82x | 5.47x | 5.03x | 2.69x | 1.88x | 2.38x | 2.03x | 2.03x |
| Quick Ratio | 3.16x | 0.54x | 4.82x | 5.47x | 5.03x | 2.69x | 1.88x | 2.38x | 2.03x | 2.03x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | -239.38 | -391.39 |
| Total Non-Current Liabilities | 33.65M | 51.82M | 336.48K | 83.89M | 70.99M | 66.64M | 118.43M | 121.49M | 141.14M | 77.11M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 71.03M | 72.12M | 73.22M | 0 |
| Capital Lease Obligations | 5.46K | 34.3K | 7.1K | 21.5M | 19.67M | 20.36M | 17.33M | 12.95M | 7.52M | 27.19M |
| Deferred Tax Liabilities | -588.49K | -266.29K | -201.26K | 195.05K | 213.72K | 196K | 186K | 0 | 0 | 0 |
| Other Non-Current Liabilities | 33.64M | 51.78M | 329.38K | 1.65M | 1.81M | 3.03M | 2.44M | 2.4M | 2.82M | 6.98M |
| Total Liabilities | 39.69M | 73.22M | 15.84M | 133.09M | 125.14M | 134.76M | 200.5M | 188.57M | 201.92M | 230.03M |
| Total Debt | 11.47K | 1.51M | 34.3K | 23.18M | 22.25M | 23.73M | 92.25M | 89.26M | 84.8M | 88.06M |
| Net Debt | -17.47M | -7.04M | -68.05M | -204.05M | -187.27M | -113.97M | -23.27M | -40.3M | -18.86M | 73.22M |
| Debt / Equity | - | - | 0.00x | 0.12x | 0.09x | 0.13x | 0.78x | 0.65x | 1.25x | 1.25x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.58x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.48x |
| Interest Coverage | -788.70x | -739.21x | -2336.42x | -1198.63x | -449.37x | -252.63x | -23.53x | -10.35x | -12.37x | -12.44x |
| Total Equity | -17.14M▲ 0% | -47.37M▼ 176.4% | 81.06M▲ 271.1% | 190.8M▲ 135.4% | 238.56M▲ 25.0% | 185.4M▼ 22.3% | 117.74M▼ 36.5% | 138.18M▲ 17.4% | 67.83M▼ 50.9% | -40.56M▲ 0% |
| Equity Growth % | - | -176.36% | 271.14% | 135.39% | 25.03% | -22.28% | -36.5% | 17.36% | -50.91% | -362.39% |
| Book Value per Share | -0.89 | -5.53 | 4.28 | 5.75 | 6.32 | 4.20 | 2.61 | 2.45 | 0.97 | -0.50 |
| Total Shareholders' Equity | -17.14M | -47.37M | 81.06M | 190.8M | 238.56M | 185.4M | 117.74M | 138.18M | 67.83M | -40.56M |
| Common Stock | 342 | 342 | 1.06K | 1.43K | 1.72K | 2K | 2K | 2K | 3K | 3K |
| Retained Earnings | -34.38M | -65.42M | -148.29M | -203.04M | -261.03M | -340.59M | -470.2M | -554.23M | -702.02M | -831.31M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -661.11K | -2.02M | 293.67K | -1.79M | -4.9M | -2.67M | 6.05M | -1.44M | -3.72M | -6.31M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MGTX Cash Flow Statement
MeiraGTx Holdings plc (MGTX) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -14.37M | -18.06M | -58.89M | 20.04M | -63.97M | -10.53M | -73.1M | -105.36M | -104.5M | -104.5M |
| Operating CF Margin % | - | - | - | 150.8% | -411.02% | -27.93% | -459.16% | -751.69% | -314% | - |
| Operating CF Growth % | - | -25.66% | -226.15% | 134.04% | -419.12% | 83.54% | -594.19% | -44.14% | 0.83% | -134.94% |
| Net Income | -19.79M | -31.04M | -82.87M | -54.75M | -57.99M | -79.56M | -129.62M | -84.03M | -147.79M | -168.69M |
| Depreciation & Amortization | 243.08K | 679.18K | 2.05M | 2.24M | 4.17M | 7.87M | 8.6M | 13.72M | 12.68M | 12.63M |
| Stock-Based Compensation | 2.81M | 2.96M | 17.88M | 15.93M | 18.42M | 20.78M | 28.62M | 27.72M | 25.19M | 22.62M |
| Deferred Taxes | -261.82K | -1.21M | -474.39K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.06M | 2.03M | 8.43M | -105.01K | 4.08M | 9.1M | 9.67M | -61.8M | -24.22M | -8.73M |
| Working Capital Changes | 1.58M | 8.53M | -3.92M | 56.73M | -32.64M | 31.28M | 9.62M | -983K | 29.64M | 25.9M |
| Change in Receivables | 0 | 0 | 0 | -32.29M | -16.12M | 16.7M | 5.17M | 4.83M | 9.43M | 903K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -387K | 428K |
| Change in Payables | 453.13K | 4.73M | -2.12M | -8.68K | 1.57M | 13.35M | 3.74M | 2.33M | 10.74M | -6.25M |
| Cash from Investing | -2.59M | -10.54M | -11.26M | -9.37M | -37.02M | -61.72M | -44.96M | 34.03M | 23.48M | -4.24M |
| Capital Expenditures | -2.59M | -10.54M | -11.26M | -8.98M | -34.89M | -55.22M | -44.96M | -20.17M | -4.96M | -4.77M |
| CapEx % of Revenue | - | - | - | 67.56% | 224.2% | 146.46% | 282.43% | 143.93% | 14.89% | - |
| Acquisitions | 0 | 0 | 0 | -389.66K | 0 | -6.5M | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | -2.13M | 0 | 0 | 54.21M | 28.43M | 536K |
| Cash from Financing | 20.76M | 19.34M | 130.04M | 148.23M | 82.73M | 1.71M | 95.2M | 84.02M | 54.53M | 11.19M |
| Debt Issued (Net) | -5.48K | 2.48M | -30.85K | -24.86K | -23K | -1K | 75M | 0 | 0 | 0 |
| Equity Issued (Net) | 1000K | 0 | 0 | 1000K | 1000K | 0 | 1000K | 1000K | 1000K | 2.77M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -230K |
| Other Financing | 0 | 16.86M | 130.07M | -6.94M | -4.3M | 1.71M | -4.8M | -7.93M | -4.86M | -2.75M |
| Net Change in Cash | 3.37M▲ 0% | -9.25M▼ 374.1% | 59.53M▲ 743.6% | 159.15M▲ 167.3% | -17.84M▼ 111.2% | -71.82M▼ 302.6% | -22.19M▲ 69.1% | 15.13M▲ 168.2% | -24.98M▼ 265.1% | -107.92M▲ 0% |
| Free Cash Flow | -16.96M▲ 0% | -28.59M▼ 68.6% | -70.15M▼ 145.3% | 11.06M▲ 115.8% | -100.99M▼ 1012.7% | -65.75M▲ 34.9% | -118.06M▼ 79.6% | -125.54M▼ 6.3% | -109.45M▲ 12.8% | -121.04M▲ 0% |
| FCF Margin % | - | - | - | 83.24% | -648.89% | -174.39% | -741.59% | -895.62% | -328.89% | -441.47% |
| FCF Growth % | - | -68.56% | -145.34% | 115.77% | -1012.71% | 34.9% | -79.57% | -6.33% | 12.82% | -18.05% |
| FCF per Share | -0.88 | -3.34 | -3.70 | 0.33 | -2.68 | -1.49 | -2.61 | -2.22 | -1.57 | -1.57 |
| FCF Conversion (FCF/Net Income) | 0.74x | 0.58x | 0.71x | -0.37x | 1.10x | 0.13x | 0.56x | 1.25x | 0.71x | 0.72x |
| Interest Paid | 0 | 0 | 0 | 1.46K | 3K | 139K | 329K | 13.05M | 12.03M | 11.44M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MGTX Key Ratios
MeiraGTx Holdings plc (MGTX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | -491.87% | -40.28% | -27.01% | -37.53% | -85.52% | -65.67% | -143.48% | -1065.47% |
| Return on Invested Capital (ROIC) | - | -450.13% | - | -246.7% | -88.93% | -105.2% | -106.89% | -167.75% | -167.75% |
| Gross Margin | - | - | 100% | 100% | 100% | 100% | 100% | 28.51% | 41.01% |
| Net Margin | - | - | -411.87% | -372.63% | -211.03% | -814.16% | -599.46% | -444.1% | -615.27% |
| Debt / Equity | - | 0.00x | 0.12x | 0.09x | 0.13x | 0.78x | 0.65x | 1.25x | 1.25x |
| Interest Coverage | -739.21x | -2336.42x | -1198.63x | -449.37x | -252.63x | -23.53x | -10.35x | -12.37x | -12.44x |
| FCF Conversion | 0.58x | 0.71x | -0.37x | 1.10x | 0.13x | 0.56x | 1.25x | 0.71x | 0.72x |
| Revenue Growth | - | - | - | 17.09% | 142.25% | -57.77% | -11.95% | 137.42% | 96.83% |
MGTX SEC Filings & Documents
MeiraGTx Holdings plc (MGTX) SEC filings — annual & quarterly reports (10-K, 10-Q)
MGTX Frequently Asked Questions
MeiraGTx Holdings plc (MGTX) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
MeiraGTx Holdings plc (MGTX) reported $27.4M in revenue for fiscal year 2024.
MeiraGTx Holdings plc (MGTX) grew revenue by 137.4% over the past year. This is strong growth.
MeiraGTx Holdings plc (MGTX) reported a net loss of $168.7M for fiscal year 2024.
Dividend & Returns
MeiraGTx Holdings plc (MGTX) has a return on equity (ROE) of -143.5%. Negative ROE indicates the company is unprofitable.
MeiraGTx Holdings plc (MGTX) had negative free cash flow of $121.0M in fiscal year 2024, likely due to heavy capital investments.
Explore More MGTX
MeiraGTx Holdings plc (MGTX) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates